StockGlow

Scopus BioPharma Inc. (SCPS)

Develops cancer drugs that reactivate immune cells to fight tumors.

$0.00+0.00%Healthcare
Compare SCPS with
StockGlow Score
56
Neutral
BearishBullish
1 year ago+66.7%

The outlook

SCPS is trading near its 52-week low at a penny-stock price point. The stock sits above both its 50- and 200-day moving averages, showing modest upward positioning in the near term. Analyst coverage appears limited, and the neutral sentiment score reflects mixed signals across available data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$21,042
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

WNWMeiwu Technology Company Limited$2.46-4.28%GLSIGreenwich LifeSciences, Inc.$13.64+1.48%VVOSVivos Therapeutics, Inc.$0.42+3.75%OCGOriental Culture Holding LTD$1.89+9.59%YGMZFMingZhu Logistics Holdings Limited$0.00+48.78%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy